Riskpilot← Back to searchSign inGet full accessLunds IVF Center AB
ABActiveOrg 5592536683Stortorget 1Medical specialists activities · NACE 8622Est. 20204 employees
Revenue 2024
SEK 12,5M
+44% vs 2023
EBITDA margin
23.8%
+23% vs 2023
Equity ratio
26.4%
Financial strength
Net profit 2024
SEK 902K
+448% vs 2023
| Revenue | SEK 12,5M | +44% |
| EBITDA | SEK 3M | +23% |
| Net profit | SEK 902K | +448% |
| Total assets | SEK 8M | -2% |
| Equity | SEK 2,1M | +49% |
| Employees | 4 | — |
Legal name
Lunds IVF Center AB
Org number
5592536683
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
27 april 2020
Share capital
SEK 26 000
Employees
4 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Aktiebolaget ska bedriva hälso- och sjukvård och därmed förenlig verksamhet
Address
Stortorget 1
Email
zahra@lundsivfcenter.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 2 657 | 6 530 | 8 636 | 12 466 |
| Staff expenses | — | — | −2 055 | −2 623 | — |
| EBITDA | −29 | 652 | 2 207 | 2 415 | 2 965 |
| Depreciation & amort. | −0 | −549 | −1 151 | −1 239 | −1 292 |
| EBIT | −29 | 103 | 1 056 | 1 177 | 1 673 |
| Net financials | −18 | −101 | −83 | −332 | −145 |
| Profit before tax | 4 | 1 | 725 | 170 | 1 141 |
| Tax | −1 | −0 | — | −6 | −239 |
| Net profit | 3 | 1 | 725 | 165 | 902 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 4 749 | 6 270 | 8 920 | 8 234 | 8 037 |
| Equity | 28 | 529 | 1 254 | 1 419 | 2 120 |
| Long-term debt | 3 950 | 3 950 | 1 863 | 3 408 | 3 013 |
| Short-term debt | 771 | 1 790 | 5 556 | 2 486 | 1 595 |
| Total debt | 4 721 | 5 740 | 7 418 | 5 893 | 4 608 |
EBITDA margin
23.8%
This company
15.8%
Market median
+51% vs market
20202024
Equity ratio
26.4%
This company
38.2%
Market median
-31% vs market
20202024
Return on equity
42.5%
This company
18.4%
Market median
+131% vs market
20202024
Net profit margin
7.2%
This company
8.1%
Market median
-11% vs market
20202024
Asset turnover
1.55×
This company
1.12×
Market median
+38% vs market
20202024
Debt / equity
2.79×
This company
0.62×
Market median
-350% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-04-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
ZS Chief Executive Officer | Chief Executive Officer | 2022 |
ME | Audit | 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Lunds IVF Center AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Zahra Sara Sabeti Rad | Chief Executive Officer | 0 companies |
| Marie Elisabeth Jönsson | Audit | 0 companies |
| Ansieh Sabetirad | Deputy Board Member | 0 companies |